Angiotensin receptor blockers (ARBs) in hypertension patients: earlier use of these better-tolerated medications is warranted
- PMID: 20532444
- PMCID: PMC5566082
Angiotensin receptor blockers (ARBs) in hypertension patients: earlier use of these better-tolerated medications is warranted
Similar articles
-
Uptake of angiotensin II receptor blockers in the treatment of hypertension.Eur J Clin Pharmacol. 2005 Jul;61(5-6):461-6. doi: 10.1007/s00228-005-0924-7. Epub 2005 May 24. Eur J Clin Pharmacol. 2005. PMID: 15912393
-
Therapeutic potential of angiotensin receptor blockers in hypertension.Expert Opin Investig Drugs. 2006 Jun;15(6):625-35. doi: 10.1517/13543784.15.6.625. Expert Opin Investig Drugs. 2006. PMID: 16732715 Review.
-
Assessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertension.J Hum Hypertens. 2009 Jun;23(6):420-5. doi: 10.1038/jhh.2008.139. Epub 2008 Dec 4. J Hum Hypertens. 2009. PMID: 19052566
-
Angiotensin II type 1 receptor blockade: high hopes sent back to reality?Minerva Cardioangiol. 2009 Dec;57(6):773-85. Minerva Cardioangiol. 2009. PMID: 19942847 Review.
-
[Assessment of the utilization of angiotensin receptor blockers in hypertension].Farm Hosp. 2013 Sep-Oct;37(5):394-8. doi: 10.7399/FH.2013.37.5.770. Farm Hosp. 2013. PMID: 24128102 Spanish.
Cited by
-
RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus.Int J Diabetes Dev Ctries. 2022 Oct;42(4):576-605. doi: 10.1007/s13410-022-01143-7. Epub 2022 Dec 15. Int J Diabetes Dev Ctries. 2022. PMID: 36536953 Free PMC article. Review.
References
-
- et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913. Leurington. - PubMed
-
- Neldam S. Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both? Future Cardiol. 2010;6(1):129–135. - PubMed
-
- Williams B, Lacourciere Y, Schumacher H, Gosse P, Neutel JM. Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials. J Hum Hpertens. 2009;23(9):610–619. - PubMed
-
- Lacouriere Y, Krezesinski JM, White WB, Davidai G, Schumacher H. Sustained antihypertensive activity of telmisartan compared with Valsartan. Blood Pres Monit. 2004;9:203–210. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical